Cargando…
Impaired Fibrinolysis in Angiographically Documented Coronary Artery Disease
Impaired fibrinolysis may predispose to coronary artery disease (CAD). Hypofibrinolysis due to high levels of plasminogen activator inhibitor-1 (PAI-1) has been reported in CAD. A novel regulator of fibrinolytic activity, thrombin activatable fibrinolysis inhibitor (TAFI), has attracted attention in...
Autores principales: | Fernandes, Adriano Basques, Lima, Luciana Moreira, Sousa, Marinez Oliveira, Toledo, Vicente de Paulo Coelho, Kazmi, Rashid Saeed, Lwaleed, Bashir Abdulgader, Carvalho, Maria das Graças |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355601/ https://www.ncbi.nlm.nih.gov/pubmed/25810721 http://dx.doi.org/10.1155/2015/214680 |
Ejemplares similares
-
Plasminogen and fibrinogen plasma levels in coronary artery disease
por: Kazmi, Rashid S., et al.
Publicado: (2012) -
Plasminogen and fibrinogen plasma levels in coronary artery disease
por: Lima, Luciana Moreira, et al.
Publicado: (2012) -
Angiographic outcomes in STEMI patients receiving fibrinolysis with guideline directed optimal antithrombotic therapy
por: Durdana, Shazia, et al.
Publicado: (2021) -
COVID-19 pandemic: multilevel dental technical guidelines based on new scientific evidence
por: Andrade, Sérgio Araújo, et al.
Publicado: (2022) -
Documentation of corneal epithelial defects with a fluorescein angiographic imaging system
por: Tripathy, Koushik
Publicado: (2019)